AR vs In Person Simulation for Medical Workplace Training

Not Applicable

Completed

• Conditions: Augmented Reality
• Interventions: Behavioral: Augmented Reality Headset

• Registration Number: NCT05674188
• Lead Sponsor: Stanford University

Brief Summary

This study will evaluate the physiologic and emotional effects of an augmented reality (AR) simulation versus an in-person simulation. This is a single institution, non-inferiority, randomized controlled trial. The target enrollment will be 100 participants in each group for a total of 200 participants. One group will wear an AR headset and participate in an AR medical crisis scenario and the other group will participate in the same scenario with a traditional, mannequin based in situ simulation.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-12-21
• Study First Submitted QC: 2022-12-21
• Study First Posted: 2023-01-06
• Study Start: 2023-03-20
• Primary Completion: 2023-03-22
• Study Completion: 2023-03-22
• Status Verified: 2023-12
• Last Update Submitted: 2023-12-27
• Last Update Posted: 2024-01-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 111

Inclusion Criteria

• Hospital providers, including nurses, physician assistants, physicians, physician trainees, and other healthcare workers at Lucile Packard Children's Hospital (LPCH) and affiliated facilities who communicate with patients daily will be included

Exclusion Criteria

• Participants with reported severe motion sickness
• Nausea
• Seizure disorder
• Currently using chronotropic heart medications, such as β blockers

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Augmented Reality Enhanced Simulation (Treatment group)	Augmented Reality Headset	Participants will experience augmented simulations with a holographic mixed-reality setting based on different workplace scenarios such as medical error and workplace harassment via Augmented Reality (AR) headset.

Primary Outcome Measures

Name	Time	Method
Parasympathetic response indexed by RSA	Duration of simulation (15-20 minutes)	Measured via respiratory sinus arrhythmia (RSA) in hertz using chest biometric sensors in 30-second epochs.

Secondary Outcome Measures

Name	Time	Method
ISO 9241-400	Post-simulation (5 minutes)	6-item ergonomic questionnaire with a scale from 1- 5, 1 being strongly disagree to 5 being strongly agree on a five-point Likert scale only administered to the AR group.
Sytem Usability Scale (SUS)	Post-simulation (5 minutes)	10-item questionnaire with a scale from 1- 5, 1 being strongly disagree to 5 being strongly agree on a five-point Likert scale to measure usability. Only administered to the AR group.
Simulation Design Scale (SDS)	Post-simulation (5-10 minutes)	20-item questionnaire with a scale from 1- 5, 1 being strongly disagree to 5 being strongly agree on a five-point Likert scale to assess user satisfaction
Learning effectiveness	5 months-post simulation (5 minutes)	Five months post-simulation, an assessment was sent out to participants with a 10-item, multiple choice with questions related to key learning points about resuscitation management.

Trial Locations

Locations (1)

Lucile Packard Children's Hospital Stanford; 🇺🇸 Palo Alto, California, United States